Who can use lapatinib(Tykerb)?

The specific medical conditions this drug is approved to treat.

Approved Uses

TYKERB is indicated in combination with capecitabine for treating patients with advanced or metastatic HER2-positive breast cancer who have received prior therapy including an anthracycline, a taxane, and trastuzumab, and whose disease has progressed on trastuzumab. It is also indicated in combination with letrozole for postmenopausal women with hormone receptor-positive, HER2-positive metastatic breast cancer for whom hormonal therapy is indicated.